195 related articles for article (PubMed ID: 34443487)
1. Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives.
Guan YF; Liu XJ; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Li W; Zhang SY
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443487
[TBL] [Abstract][Full Text] [Related]
2. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents.
Lu CF; Wang SH; Pang XJ; Zhu T; Li HL; Li QR; Li QY; Gu YF; Mu ZY; Jin MJ; Li YR; Hu YY; Zhang YB; Song J; Zhang SY
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255804
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and molecular docking study of novel quinoline-based bis-chalcones as potential antitumor agents.
Insuasty D; García S; Abonia R; Insuasty B; Quiroga J; Nogueras M; Cobo J; Borosky GL; Laali KK
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100094. PubMed ID: 34050547
[TBL] [Abstract][Full Text] [Related]
5. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.
Li W; Xu F; Shuai W; Sun H; Yao H; Ma C; Xu S; Yao H; Zhu Z; Yang DH; Chen ZS; Xu J
J Med Chem; 2019 Jan; 62(2):993-1013. PubMed ID: 30525584
[TBL] [Abstract][Full Text] [Related]
7. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents.
Burmaoglu S; Gobek A; Aydin BO; Yurtoglu E; Aydin BN; Ozkat GY; Hepokur C; Ozek NS; Aysin F; Altundas R; Algul O
Bioorg Chem; 2021 Jun; 111():104882. PubMed ID: 33839582
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.
Ren Y; Ruan Y; Cheng B; Li L; Liu J; Fang Y; Chen J
Bioorg Med Chem; 2021 Sep; 46():116376. PubMed ID: 34455231
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors.
Jin XY; Chen H; Li DD; Li AL; Wang WY; Gu W
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):955-972. PubMed ID: 31072147
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and cytotoxic evaluation of novel furo[2,3-b]quinoline derivatives.
Wang B; Li Q; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2018 Apr; 91(4):957-961. PubMed ID: 29197162
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
Bioorg Chem; 2020 Jan; 95():103565. PubMed ID: 31927336
[TBL] [Abstract][Full Text] [Related]
16. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.
Sun M; Yuan M; Kang Y; Qin J; Zhang Y; Duan Y; Wang L; Yao Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):339-354. PubMed ID: 34979843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
